Contineum Therapeutics, Inc. (CTNM) stock
CTNMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.55−0.12 (-1.24%)
Close on Nov 17, 2026Market cap $359.28MP/E –Yield –
Contineum Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Contineum Therapeutics's price to sales ratio was 0.7× on Apr 30, 2024.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Apr 30, 2024 | 0.7× | – |
See a number that looks wrong?